UB#WUXI RC2609A(63424.HK)

Last Updated 08:00:00
longbridge loading
Company Encyclopedia
View More
name
UB#WUXI RC2609A
63424.HK
News
View More

Morgan Stanley's long position in Wuxi Biologics (Cayman) decreases to 2.11% on Jan 20 from 5.58%, HKEX shows

Morgan Stanley's long position in Wuxi Biologics (Cayman) decreases to 2.11% on Jan 20 from 5.58%, HKEX shows

marketscreener·
HK
02269
+0.92%
marketscreener·
HK
02269
+0.92%

Hong Kong Equities Edge Up After Recent Declines

Hong Kong stocks rose 32 points (0.1%) to 26,518, breaking a four-session losing streak, influenced by stronger U.S. futures. The rebound was led by tech and consumer sectors, reflecting gains in mainland markets after the People's Bank of China maintained lending rates. However, investor caution persisted ahead of upcoming inflation data and business confidence readings. Notable early movers included Wuxi Biologics (2.6%), SMIC (2.5%), Zijin Mining (2.2%), and China Hongqiao Group (1.9%).

Trading Economics·
US
WXXWY
0.00%
HK
02269
+0.92%
Trading Economics·
US
WXXWY
0.00%
HK
02269
+0.92%

Top 5 HK Stock Gainers/Losers (>100B) (1.19)

CHINA EAST AIR(00670) rose 9.2%, with a trading turnover 216.5 Million HKD, and a year-to-date rose 6.9%. CTG DUTY-FREE(01880) rose 6.65%, with a trading turnover 350.2 Million HKD, and a year-to-date rose 10.8%. MINIMAX-WP(00100) fell 13.7%, with a trading turnover 649.0 Million HKD, and a year-to-date rose 129.1%. BILIBILI-W(09626) fell 6.85%, with a trading turnover 1.7 Billion HKD, and a year-to-date rose 25.6%.

Top Gainers & Losers·
HK
00670
-4.14%
HK
01880
+2.29%
HK
03986
+5.97%
Top Gainers & Losers·
HK
00670
-4.14%
HK
01880
+2.29%
HK
03986
+5.97%

"New Stocks" Doning Biotechnology applies for listing in Hong Kong, WuXi Biologics is the largest customer

Douning Biotechnology has submitted a listing application to the Hong Kong Stock Exchange, with Morgan Stanley and Huatai International as its joint sponsors. The company primarily provides bioprocess solutions for pharmaceutical companies and research institutions, with WuXi Biologics as its largest client. In the first three quarters of 2023, Douning Biotechnology recorded revenue of RMB 658 million, a year-on-year increase of 19.4%, achieving a net profit of approximately RMB 21.604 million. The funds raised from the listing will be used to expand products, establish overseas production lines, and enhance research and development capabilities

AASTOCKS·
US
WXXWY
0.00%
HK
02269
+0.92%
AASTOCKS·
US
WXXWY
0.00%
HK
02269
+0.92%

Hong Kong Stock Market Closing | The Hang Seng Index fell 0.29%, with a divergence in the technology and retail sectors, while popular stocks like MINIMAX-WP surged significantly

On January 16th, the three major indices of the Hong Kong stock market experienced slight adjustments, with the Hang Seng Index and the Hang Seng TECH Index retreating slightly, and the previous gains failing to continue. Mainstream sectors showed divergence, with retail and internet leaders exhibiting fluctuating performances. Short-term capital focused on technology and high-tech concepts, with notable gains in popular stocks such as MINIMAX-WP and SYNAGISTICS. The market is highly sensitive to liquidity, macroeconomic recovery, and corporate profit expectations, with an overall moderate risk appetite

Market Heartbeat·
HK
02269
+0.92%
HK
03986
+5.97%
Market Heartbeat·
HK
02269
+0.92%
HK
03986
+5.97%
Posts
View More
© 2026 Longbridge｜Disclaimer